Germany: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Germany

The German human and animal blood market soared to $X in 2021, increasing by X% against the previous year. Overall, consumption saw resilient growth. Human and animal blood consumption peaked in 2021 and is expected to retain growth in the immediate term.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Germany

In value terms, human and animal blood production dropped slightly to $X in 2021 estimated in export price. The total output value increased at an average annual rate of +X% over the period from 2012 to 2021; the trend pattern remained relatively stable, with only minor fluctuations being observed in certain years. The pace of growth was the most pronounced in 2013 when the production volume increased by X%. Human and animal blood production peaked at $X in 2020, and then fell modestly in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from Germany

In 2021, exports of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses from Germany rose notably to X tons, surging by X% against the year before. Over the period under review, total exports indicated a prominent increase from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +X% against 2012 indices. The most prominent rate of growth was recorded in 2017 when exports increased by X%. Over the period under review, the exports hit record highs in 2021 and are likely to continue growth in years to come.

In value terms, human and animal blood exports surged to $X in 2021. Overall, exports recorded resilient growth. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

Exports by Country

The United States (X tons), France (X tons) and Denmark (X tons) were the main destinations of human and animal blood exports from Germany, with a combined X% share of total exports. Poland, the Netherlands, Russia, the Czech Republic, China, Brazil, Austria, Spain, Switzerland and the UK lagged somewhat behind, together accounting for a further X 2012 to 2021, the biggest increases were in China (with a CAGR of +X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the United States ($X) remains the key foreign market for human and animal blood exports from Germany, comprising X% of total exports. The second position in the ranking was taken by France ($X), with a X% share of total exports. It was followed by China, with a X% share.

From 2012 to 2021, the average annual rate of growth in terms of value to the United States stood at +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: France (+X% per year) and China (+X% per year).

Export Prices by Country

The average human and animal blood export price stood at $X per ton in 2021, growing by X% against the previous year. Overall, export price indicated a prominent increase from 2012 to 2021: its price increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, human and animal blood export price increased by +X% against 2015 indices. As a result, the export price attained the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by the country of destination: the country with the highest price was the UK ($X per ton), while the average price for exports to Denmark ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the Netherlands (+X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into Germany

Human and animal blood imports into Germany skyrocketed to X tons in 2021, with an increase of X% compared with 2020 figures. In general, total imports indicated strong growth from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2018 indices. As a result, imports attained the peak and are likely to continue growth in the immediate term.

In value terms, human and animal blood imports soared to $X in 2021. Overall, imports showed a prominent expansion. The pace of growth appeared the most rapid in 2020 with an increase of X%. Over the period under review, imports reached the peak figure in 2021 and are expected to retain growth in years to come.

Imports by Country

Ireland (X tons), Denmark (X tons) and Switzerland (X tons) were the main suppliers of human and animal blood imports to Germany, with a combined X% share of total imports. These countries were followed by the Netherlands, France, China and the United States, which together accounted for a further X 2012 to 2021, the biggest increases were in China (with a CAGR of +X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest human and animal blood suppliers to Germany were the United States ($X), Ireland ($X) and Switzerland ($X), together accounting for X% of total imports. The Netherlands, France, Denmark and China lagged somewhat behind, together comprising a further X, with a CAGR of +X%, saw the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2021, falling by -X% against the previous year. Overall, the import price, however, posted a moderate increase. The growth pace was the most rapid in 2020 when the average import price increased by X%. As a result, import price reached the peak level of $X per ton, and then shrank modestly in the following year.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was the United States ($X per ton), while the price for Denmark ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the United States (+X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :